These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37517604)

  • 1. Comparison and summary of in silico prediction tools for CYP450-mediated drug metabolism.
    Zhai J; Man VH; Ji B; Cai L; Wang J
    Drug Discov Today; 2023 Oct; 28(10):103728. PubMed ID: 37517604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.
    Emoto C; Murayama N; Rostami-Hodjegan A; Yamazaki H
    Curr Drug Metab; 2010 Oct; 11(8):678-85. PubMed ID: 20973757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Computational methods and tools to predict cytochrome P450 metabolism for drug discovery.
    Tyzack JD; Kirchmair J
    Chem Biol Drug Des; 2019 Apr; 93(4):377-386. PubMed ID: 30471192
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of cytochrome-P450 inhibition (CYP) in drug discovery: a medicinal chemistry perspective.
    Kumar S; Sharma R; Roychowdhury A
    Curr Med Chem; 2012; 19(21):3605-21. PubMed ID: 22680629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SOMEViz: a web service for site of metabolism estimating and visualizing.
    Shen Q; Zheng M; Lu J; Luo C; Zhu W; Chen K; Luo X; Jiang H
    Protein Pept Lett; 2012 Sep; 19(9):905-9. PubMed ID: 22894162
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CyProduct: A Software Tool for Accurately Predicting the Byproducts of Human Cytochrome P450 Metabolism.
    Tian S; Cao X; Greiner R; Li C; Guo A; Wishart DS
    J Chem Inf Model; 2021 Jun; 61(6):3128-3140. PubMed ID: 34038112
    [No Abstract]   [Full Text] [Related]  

  • 7. Flavokawain A inhibits Cytochrome P450 in in vitro metabolic and inhibitory investigations.
    Niu L; Ding L; Lu C; Zuo F; Yao K; Xu S; Li W; Yang D; Xu X
    J Ethnopharmacol; 2016 Sep; 191():350-359. PubMed ID: 27318274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADMET Evaluation in Drug Discovery. 19. Reliable Prediction of Human Cytochrome P450 Inhibition Using Artificial Intelligence Approaches.
    Wu Z; Lei T; Shen C; Wang Z; Cao D; Hou T
    J Chem Inf Model; 2019 Nov; 59(11):4587-4601. PubMed ID: 31644282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 Structure, Function and Clinical Significance: A Review.
    Manikandan P; Nagini S
    Curr Drug Targets; 2018; 19(1):38-54. PubMed ID: 28124606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of support vector machines to in silico prediction of cytochrome p450 enzyme substrates and inhibitors.
    Yap CW; Xue Y; Li ZR; Chen YZ
    Curr Top Med Chem; 2006; 6(15):1593-607. PubMed ID: 16918471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorescence-Based High-Throughput Assays for Investigating Cytochrome P450 Enzyme-Mediated Drug-Drug Interactions.
    He R; Dai Z; Finel M; Zhang F; Tu D; Yang L; Ge G
    Drug Metab Dispos; 2023 Oct; 51(10):1254-1272. PubMed ID: 37349113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Towards Predicting the Cytochrome P450 Modulation: From QSAR to Proteochemometric Modeling.
    Shoombuatong W; Prathipati P; Prachayasittikul V; Schaduangrat N; Malik AA; Pratiwi R; Wanwimolruk S; Wikberg JES; Gleeson MP; Spjuth O; Nantasenamat C
    Curr Drug Metab; 2017 Jul; 18(6):540-555. PubMed ID: 28322159
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CypReact: A Software Tool for in Silico Reactant Prediction for Human Cytochrome P450 Enzymes.
    Tian S; Djoumbou-Feunang Y; Greiner R; Wishart DS
    J Chem Inf Model; 2018 Jun; 58(6):1282-1291. PubMed ID: 29738669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In silico site of metabolism prediction of cytochrome P450-mediated biotransformations.
    Tarcsay Á; Keseru GM
    Expert Opin Drug Metab Toxicol; 2011 Mar; 7(3):299-312. PubMed ID: 21291341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of cytochrome P450 drug interaction screening in drug discovery.
    Foti RS; Wienkers LC; Wahlstrom JL
    Comb Chem High Throughput Screen; 2010 Feb; 13(2):145-58. PubMed ID: 20053168
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The current status of time dependent CYP inhibition assay and in silico drug-drug interaction predictions.
    Yan Z; Caldwell GW
    Curr Top Med Chem; 2012; 12(11):1291-7. PubMed ID: 22571791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Robust Machine Learning Framework Built Upon Molecular Representations Predicts CYP450 Inhibition: Toward Precision in Drug Repurposing.
    Ouzounis S; Panagiotopoulos V; Bafiti V; Zoumpoulakis P; Cavouras D; Kalatzis I; Matsoukas MT; Katsila T
    OMICS; 2023 Jul; 27(7):305-314. PubMed ID: 37406257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of lung cancer patients and concomitant use of drugs interacting with cytochrome P450 isoenzymes.
    Song X; Varker H; Eichelbaum M; Stopfer P; Shahidi M; Wilson K; Kaiser R; Finnern HW
    Lung Cancer; 2011 Oct; 74(1):103-11. PubMed ID: 21382644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved Prediction of Michaelis Constants in CYP450-Mediated Reactions by Resilient Back Propagation Algorithm.
    Dai H; Xu Q; Xiong Y; Liu WL; Wei DQ
    Curr Drug Metab; 2016; 17(7):673-80. PubMed ID: 27174458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of liposomal curcumin cytochrome p450 metabolism.
    Mach CM; Chen JH; Mosley SA; Kurzrock R; Smith JA
    Anticancer Res; 2010 Mar; 30(3):811-4. PubMed ID: 20393001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.